December 21, 2016
Takeda makes EUR10 million equity investment in TiGenix
Belgian based biopharmaceutical company TiGenix has exercised the option granted by Takeda under the licensing agreement to make a EUR10…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Business
December 21, 2016
Ipsen to sell Exelixis’s cabozantinib in Canada
Exelixis and Ipsen have signed an amendment to the exclusive collaboration and licensing agreement for the commercialization and continued development…
December 21, 2016
Bayer and Leica Biosystems unite to fight cancer
Bayer has entered into an agreement with Leica Biosystems to collaborate on the development of companion diagnostic tests based on…
December 21, 2016
Premaitha buys Taiwanian bioinformatic company
Premaitha has announced the conditional acquisition of the entire issued share capital of Yourgene.
December 20, 2016
Allergan eats LifeCell for $2,9 billion
Allergan has acquired the regenerative medicine company LifeCell for $2.9 billion in cash.
December 20, 2016
BMS gets exclusive rights to study PsiOxus’s cancer drug
Bristol-Myers Squibb and PsiOxus Therapeutics have entered into an agreement granting Bristol-Myers Squibb exclusive worldwide rights to NG-348, a pre-clinical…
December 20, 2016
Novartis buys private US-based pharma company, exapnds its ophtalmology pipeline
Novarits is expanding its ophthalmology pipeline as it secured the ownership of a US-based private company focused on treating long-sightedness.
December 20, 2016
Biogen names Michel Vounatsos new CEO
Biogen’s Board of Directors has appointed Michel Vounatsos as Chief Executive Officer and member of the Board of Directors, effective…
December 20, 2016
Silence Therapeutics settles with Quark Pharmaceuticals
Silence Therapeutics and Quark Pharmaceuticals have settled in the arbitration regarding a milestone payment, as Silence is to receive a…
December 20, 2016
Novartis, Conatus in borad deal to make treatments for liver diseases
Novartis and Conatus Pharmaceuticals have signed a multipurpose deal which will help the two drug makers to make liver-disease treatment,…